Diagnostic approaches in COVID-19: clinical updates

References

• Atlas RM. Bioterrorism: from threat to reality. Annu Rev Microbiol. 2002;56(1):167–185.
   PubMedGoogle Scholar
• Charaya N, Singh H, Sidhu SK, et al. Microbial forensic’s-microbes as a part of forensic investigation. J Adv Med Dent Sci Res. 2016;4(4):32.
   Google Scholar
• Thavaselvam D, Vijayaraghavan R. Biological warfare agents. J Pharm Bioallied Sci. 2010;2(3):179.
   PubMedGoogle Scholar
• Hays JN. Epidemics and pandemics: their impacts on human history. Abc-clio, Inc.; 2005.
   Google Scholar
• Lai -C-C, Shih T-P, Ko W-C, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924.
   PubMed Web of Science ®Google Scholar
• Siddell SG, Ziebuhr J, Snijder EJ. Coronaviruses, toroviruses, and arteriviruses. Topley & Wilson’s Microbiology and Microbial Infections. John Willey & Sons, Ltd.; 2010.
   Google Scholar
• Perlman S. Another decade, another coronavirus. Mass Medical Soc; N Engl J Med. 2020.
   Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Lam TT-Y, Shum H-H M, Zhu H-C, et al. Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. BioRxiv. 2020.
   PubMedGoogle Scholar
• Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16(10):1678.
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422.
   PubMed Web of Science ®Google Scholar
• Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907–1916.
   PubMed Web of Science ®Google Scholar
• Yang M. 2020. Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. SSRN 3527420.
   Google Scholar
• Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–116.
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Penninger JM. The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol. 2008;93(5):543–548.
   PubMed Web of Science ®Google Scholar
• Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6(3):271–276.
   PubMed Web of Science ®Google Scholar
• Lambert DW, Yarski M, Warner FJ, et al. Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem. 2005;280(34):30113–30119.
   PubMed Web of Science ®Google Scholar
• Glowacka I, Bertram S, Herzog P, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 2010;84(2):1198–1205.
   PubMed Web of Science ®Google Scholar
• Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53:368–370.
   Google Scholar
• Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020;35:266–271.
   Web of Science ®Google Scholar
• Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus and COVID-19 pandemic: a review. Int J Surg. 2020;78:185–193.
   PubMed Web of Science ®Google Scholar
• Ravalli S, Musumeci G. Coronavirus outbreak in italy: physiological benefits of home-based exercise during pandemic. Multidisciplinary Digital Publishing Institute; 2020;5:31.
   Google Scholar
• Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–920.
   PubMed Web of Science ®Google Scholar
• Campbell JP, Turner JE. Debunking the myth of exercise-induced immune suppression: redefining the impact of exercise on immunological health across the lifespan. Front Immunol. 2018;9:648.
   PubMed Web of Science ®Google Scholar
• Paoli A, Musumeci G. Elite athletes and COVID-19 lockdown: future health concerns for an entire sector. Multidisciplinary Digital Publishing Institute; 2020;5:30.
   Google Scholar
• Mujika I, Padilla S. Detraining: loss of training-induced physiological and performance adaptations. Part I. Sports Med. 2000;30(2):79–87.
   PubMed Web of Science ®Google Scholar
• Frizziero A, Salamanna F, Della Bella E, et al. The role of detraining in tendon mechanobiology. Front Aging Neurosci. 2016;8:43.
   PubMed Web of Science ®Google Scholar
• Giustino V, Parroco AM, Gennaro A, et al. Physical activity levels and related energy expenditure during COVID-19 Quarantine among the sicilian active population: a cross-sectional online survey study. Sustainability. 2020;12(11):4356.
   Web of Science ®Google Scholar
• Lesser IA, Nienhuis CP. The impact of COVID-19 on physical activity behavior and well-being of Canadians. Int J Environ Res Public Health. 2020;17(11):3899.
   PubMed Web of Science ®Google Scholar
• Maugeri G, Castrogiovanni P, Battaglia G, et al. The impact of physical activity on psychological health during Covid-19 pandemic in Italy. Heliyon. 2020;6(6):e04315.
   PubMed Web of Science ®Google Scholar
• Szychlinska MA, Castrogiovanni P, Trovato FM, et al. Physical activity and Mediterranean diet based on olive tree phenolic compounds from two different geographical areas have protective effects on early osteoarthritis, muscle atrophy and hepatic steatosis. Eur J Nutr. 2019;58(2):565–581.
   PubMed Web of Science ®Google Scholar
• Chan JF-W, Yip CC-Y, To KK-W, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel Real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. J Clin Microbiol. 2020;58(5). DOI:10.1128/JCM.00310-20.
   Web of Science ®Google Scholar
• Adhikari SP, Meng S, Wu Y-J, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):1–12.
   PubMed Web of Science ®Google Scholar
• Forbes BA, Sahm D, Weissfeld A. Study Guide for Bailey and Scott’s Diagnostic Microbiology eBook ISBN: 9780323263474. 12th ed. 2007 Jan 22. p. 200.
   Google Scholar
• Subbaraman N. Coronavirus tests: researchers chase new diagnostics to fight the pandemic. Nature. 2020. DOI:10.1038/d41586-020-00827-6
   Google Scholar
• Organization, W.H. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. Geneva, Switzerland: World Health Organization; 2020.
   Google Scholar
• Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929–936.
   Web of Science ®Google Scholar
• To KK-W, Tsang OT-Y, Yip CC-Y, et al. Consistent detection of 2019 novel coronavirus in saliva. Clinl Infect Dis. 2020;71:841–843.
   Web of Science ®Google Scholar
• Chan J, Kok K-H, Zhu Z, et al. Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–236.
   PubMed Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2000045.
   Web of Science ®Google Scholar
• Zhang W, Du R-H, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953–1966.
   PubMed Web of Science ®Google Scholar
• Deiris J, Lai S, Poon L. Coronavlrus as a possible cause of severe a cute respiratory syndrome. Lancet. 2003;361(9366):1319–1325.
   PubMed Web of Science ®Google Scholar
• Cai X, Chen J, Hu J, et al. A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of corona virus disease 2019 (COVID-19). medRxiv. 2020.
   Google Scholar
• Xiang J, Yan M, Li H, et al. Evaluation of enzyme-linked immunoassay and colloidal gold-immunochromatographic assay kit for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19). medRxiv. 2020.
   PubMedGoogle Scholar
• Organization, W.H. Advice on the use of point-of-care immunodiagnostic tests for COVID-19: scientific brief, 8 April 2020. World Health Organization; 2020.
   Google Scholar
• Diao B, Wen K, Chen J, et al. Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein. medRxiv. 2020.
   PubMedGoogle Scholar
• Nguyen T, Duong Bang D, Wolff A. 2019 novel coronavirus disease (COVID-19): paving the road for rapid detection and point-of-care diagnostics. Micromachines. 2020;11(3):306.
   PubMed Web of Science ®Google Scholar
• Tran NK, Godwin Z, Bockhold J. Point-of-Care Testing at the Disaster-Emergency-Critical Care Interface. Point Care. 2012 Dec 1;11(4):180–183.
   Google Scholar
• Huang P, Wang H, Cao Z, et al. A rapid and specific assay for the detection of MERS-CoV. Front Microbiol. 2018;9:1101.
   PubMed Web of Science ®Google Scholar
• Spengler M, Adler M, Niemeyer CM. Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques. Analyst. 2015;140(18):6175–6194.
   PubMed Web of Science ®Google Scholar
• Liu R, Han H, Liu F, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital iWuhan, Chinan, from Jan to Feb 2020. Clin Chim Acta. 2020;505: 172–175.
   Web of Science ®Google Scholar
• Wu X, Cai Y, Huang X, et al. Early release-co-infection with SARS-CoV-2 and influenza a virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26:1324–1326.
   Google Scholar
• Han R, Huang L, Jiang H, et al. Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia. Am J Roentgenol. 2020;215:1–6.
   Web of Science ®Google Scholar
• Zu ZY, Jiang MD, Xu PP, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;296:200490.
   PubMed Web of Science ®Google Scholar
• Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. Am J Roentgenol. 2020;1–7. DOI:10.2214/AJR.19.22372.
   PubMed Web of Science ®Google Scholar
• Li X, Geng M, Peng Y, et al. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10:102–108.
   Web of Science ®Google Scholar
• Wong HYF, Lam HYS, Fong AH-T, et al. Frequency and distribution of chest radiographic findings in COVID-19 positive patients. Radiology. 2020;296:201160.
   Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos ID, Mpesiana TA. Covid-19: automatic detection from x-ray images utilizing transfer learning with convolutional neural networks. Phys Eng Sci Med. 2020;46:635–640.
   PubMedGoogle Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061–1069.
   PubMed Web of Science ®Google Scholar
• Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020;295(1):202–207.
   PubMed Web of Science ®Google Scholar
• Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. 2020 Jun;295(3):715–721.
   Web of Science ®Google Scholar
• Song F, Shi N, Shan F, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295(1):210–217.
   PubMed Web of Science ®Google Scholar
• Kaye M, Druce J, Tran T, et al. SARS–associated coronavirus replication in cell lines. Emerg Infect Dis. 2006;12(1):128.
   PubMed Web of Science ®Google Scholar
• Gillim-Ross L, Taylor J, Scholl DR, et al. Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR. J Clin Microbiol. 2004;42(7):3196–3206.
   PubMed Web of Science ®Google Scholar
• Barrett PN, Berezuk G, Fritsch S, et al. Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2011;377(9767):751–759.
   PubMed Web of Science ®Google Scholar
• Ren X, Glende J, Al-Falah M, et al. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol. 2006;87(6):1691–1695.
   PubMedGoogle Scholar
• Harcourt J, Tamin A, Lu X, et al. Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient. BioRxiv. 2020.
   PubMedGoogle Scholar
• Matsuyama S, Nagata N, Shirato K, et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010;84(24):12658–12664.
   PubMed Web of Science ®Google Scholar
• Iwata-Yoshikawa N, Okamura T, Shimizu Y, et al. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol. 2019;93(6):e01815–18.
   PubMed Web of Science ®Google Scholar
• Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol. 2013;87(23):12552–12561.
   PubMed Web of Science ®Google Scholar
• Gierer S, Bertram S, Kaup F, et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol. 2013;87(10):5502–5511.
   PubMed Web of Science ®Google Scholar
• Matsuyama S, Nao N, Shirato K, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Nat Acad Sci. 2020;117(13):7001–7003.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
   PubMed Web of Science ®Google Scholar
• von der Thüsen J, van der Eerden M. Histopathology and genetic susceptibility in COVID‐19 pneumonia. Eur J Clin Invest. 2020;50. DOI:10.1111/eci.13259
   PubMed Web of Science ®Google Scholar
• Tian S, Hu W, Niu L, et al. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–704.
   Web of Science ®Google Scholar
• Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003;200(3):282–289.
   PubMed Web of Science ®Google Scholar
• Ng DL, Al Hosani F, Keating MK, et al. Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014. Am J Pathol. 2016;186(3):652–658.
   PubMed Web of Science ®Google Scholar
• Hanley B, Lucas SB, Youd E, et al. Autopsy in suspected COVID-19 cases. J Clin Pathol. 2020;73(5):239–242.
   PubMed Web of Science ®Google Scholar
• Barton LM, Duval EJ, Stroberg E, et al. COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol. 2020 May 5;153(6):725–733.
   Google Scholar
• Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.
   PubMed Web of Science ®Google Scholar
• Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. Inter J Infect Dis. 2020;95:304–307.
   Web of Science ®Google Scholar
• Kermali M, Khalsa RK, Pillai K, et al. The role of biomarkers in diagnosis of COVID-19–A systematic review. Life Sci. 2020;254:117788.
   PubMed Web of Science ®Google Scholar
• Broughton JP, Deng X, Yu G, et al. A protocol for rapid detection of the 2019 novel coronavirus SARS-CoV-2 using CRISPR diagnostics: SARS-CoV-2 DETECTR v3. Mammoth Biosci South San Francisco CA. 2020;38:870–874.
   Google Scholar
• Kellner MJ, Koob JG, Gootenberg JS, et al. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc. 2019;14(10):2986–3012.
   PubMed Web of Science ®Google Scholar
• Broughton JP, Deng X, Yu G, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020 Jul;38(7):870–874. Epub 2020 Apr 16.
   Google Scholar
• Hou T, Zeng W, Yang M, et al. Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19. PLoS Pathog. 2020 Aug 27;16(8):e1008705. eCollection 2020 Aug.
   Google Scholar
• Ganzenmueller T, Kaiser R, Baier C, et al. Comparison of the performance of the panther fusion respiratory virus panel to R-Gene and laboratory developed tests for diagnostic and hygiene screening specimens from the upper and lower respiratory tract. J Med Microbiol. 2020;69(3):427–435.
   PubMed Web of Science ®Google Scholar
• Novak-Weekley S, Marlowe EM, Poulter M, et al. Evaluation of the cepheid xpert flu assay for rapid identification and differentiation of influenza A, influenza A 2009 H1N1, and influenza B viruses. J Clin Microbiol. 2012;50(5):1704–1710.
   PubMed Web of Science ®Google Scholar
• Cordes AK, Heim A. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the panther fusion. J Clin Virol. 2020;125:104305.
   PubMed Web of Science ®Google Scholar
• Sam SS, Caliendo AM, Ingersoll J, et al. Evaluation of performance characteristics of panther fusion assays for detection of respiratory viruses from nasopharyngeal and lower respiratory tract specimens. J Clin Microbiol. 2018;56(8):e00787–18.
   PubMed Web of Science ®Google Scholar
• Karimi A, Rafiei Tabatabaei S, Rajabnejad M, et al. An algorithmic approach to diagnosis and treatment of coronavirus disease 2019 (COVID-19) in children: Iranian expert’s consensus statement. Arch Pediatr Infect Dis. 2020;8(2):e102400.
   Web of Science ®Google Scholar
• Zhang Y, Odiwuor N, Xiong J, et al. Rapid molecular detection of SARS-CoV-2 (COVID-19) virus RNA using colorimetric LAMP. medRxiv. 2020.
   Google Scholar
• El-Tholoth M, Bau HH, Song J. A single and two-stage, closed-tube, molecular test for the 2019 Novel Coronavirus (COVID-19) at home, clinic, and points of entry. ChemRxiv. 2020.
   Google Scholar
• Lo S-J, Yang S-C, Yao D-J, et al. Molecular-level dengue fever diagnostic devices made out of paper. Lab Chip. 2013;13(14):2686–2692.
   PubMed Web of Science ®Google Scholar
• Yang T, Wang Y-C, Shen C-F, et al. Point-of-care RNA-based diagnostic device for Covid-19. Multidisciplinary Digital Publishing Institute; 2020.
   Google Scholar
• Marchand-Senécal X, Kozak R, Mubareka S, et al. Diagnosis and management of first case of COVID-19 in Canada: lessons applied from SARS. Clinl Infect Dis. 2020. DOI:10.1093/cid/ciaa227.
   PubMed Web of Science ®Google Scholar